Filter every US stock on the same numbers behind our pages, from P/E to insider buying. Or start from one of the ready-made ideas.
Prices and filings as of the close on Oct 30, 2026
| # | Company | Share price | 1D | Market cap | Holders chg. | Inst. shares chg. | Score | P/E | Margin of safety | Rev. growth | Net margin | Yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101 | $5.32 | −5.0% | $2.6B | +11.3% | +27.3% | 9 | – | – | +13.0% | −135% | – | |
| 102 | $37.35 | −0.08% | $2.5B | +13.6% | +9.6% | 7 | – | – | +18.3% | −2.1% | – | |
| 103 |
| $10.67 |
| −8.6% |
| $2.4B |
| +16.7% |
| +35.1% |
| 3 |
| – |
| – |
| +117% |
| −26.6% |
| – |
| 104 | $160.28 | −4.6% | $2.4B | +20.5% | +7.8% | 4 | – | – | +9.2% | −2.4% | – |
| 105 | $50.79 | −4.9% | $2.4B | +32.2% | +8.1% | 8 | – | −150% | +34.0% | −4.0% | – |
| 106 | $19.69 | +2.1% | $2.4B | +12.9% | +12.1% | 7 | 75.7× | −121% | +32.2% | 4.8% | – |
| 107 | $133.06 | −5.2% | $2.4B | +20.2% | +9.4% | 10 | 76.0× | −70.4% | +4.9% | 3.7% | – |
| 108 | $21.44 | −4.6% | $2.4B | +16.6% | +5.7% | 15 | 19.9× | −12.7% | +24.3% | 26.1% | 0.93% |
| 109 | $30.10 | +0.70% | $2.4B | +11.0% | +17.8% | 7 | – | – | −97.3% | −190221% | – |
| 110 | $9.62 | −8.6% | $2.4B | +23.7% | +8.3% | 6 | – | – | – | – | – |
| 111 | $54.43 | −0.46% | $2.3B | +11.4% | +7.7% | 19 | 7.2× | +23.9% | +81.1% | 55.0% | 6.2% |
| 112 | $5.78 | −0.69% | $2.2B | +40.1% | +12.4% | 7 | – | +64.7% | +7.9% | −91.3% | – |
| 113 | $11.01 | −10.4% | $2.2B | +103% | +173% | – | – | – | – | 3230% | – |
| 114 | $29.74 | −7.5% | $2.1B | +44.5% | +19.3% | 10 | – | −122% | +62.8% | −26.0% | – |
| 115 | $8.39 | −8.4% | $2.1B | +25.2% | +15.9% | 9 | – | – | +63.1% | −57.3% | – |
| 116 | $36.53 | −0.25% | $2.0B | +22.2% | +7.5% | 8 | 44.5× | −36.4% | +58.9% | 1.1% | – |
| 117 | $7.81 | −7.7% | $2.0B | +12.7% | +18.6% | 7 | – | −183% | −5.0% | −37.1% | – |
| 118 | $8.88 | −5.8% | $2.0B | +177% | +48.4% | 7 | – | – | – | −241% | – |
| 119 | $10.28 | −3.0% | $2.0B | +1983% | +20813% | 5 | – | +20.9% | −3.9% | – | – |
| 120 | $9.68 | −4.7% | $2.0B | +20.0% | +36.7% | 7 | – | – | – | – | – |
| 121 | $71.34 | −2.1% | $2.0B | +24.9% | +41.9% | 5 | 49.5× | −54.6% | +12.2% | 0.90% | 0.00% |
| 122 | $11.52 | −4.6% | $1.9B | +18.8% | +16.7% | 7 | – | – | −36.5% | −2813% | – |
| 123 | $13.56 | −1.8% | $1.9B | +10.1% | +11.6% | 7 | – | – | – | – | – |
| 124 | $8.48 | −7.8% | $1.9B | +18.3% | +23.5% | 7 | – | – | −46.4% | – | – |
| 125 | $11.13 | −8.0% | $1.9B | +20.1% | +20.0% | 5 | – | – | −62.3% | −7756% | – |
| 126 | $37.34 | +0.35% | $1.9B | +15.3% | +5.1% | 10 | – | +3.0% | +21.1% | −0.37% | 2.3% |
| 127 | $22.20 | −10.9% | $1.9B | +25.9% | +33.7% | 6 | – | – | – | – | – |
| 128 | $62.46 | −8.7% | $1.9B | +11.9% | +6.6% | 5 | – | – | +38.6% | −15.8% | – |
| 129 | genbGenerate Biomedicines | $14.46 | −8.3% | $1.9B | +50.9% | +7.8% | – | – | – | – | – | – |
|---|
| 130 | $74.41 | −0.57% | $1.8B | +10.5% | +5.8% | 17 | 18.5× | +3.5% | +4.7% | 2.0% | 1.8% |
| 131 | $39.17 | −0.46% | $1.8B | +25.8% | +116% | 9 | 19.9× | −14.2% | +28.3% | 9.1% | – |
| 132 | $47.11 | +0.36% | $1.8B | +14.5% | +7.9% | 13 | 17.6× | +16.3% | +24.0% | 3.1% | – |
| 133 | $90.67 | −1.2% | $1.8B | +30.3% | +12.8% | 12 | 25.9× | −137% | +18.9% | 933% | – |
| 134 | $24.48 | −5.3% | $1.8B | +17.4% | +5.8% | 14 | 40.8× | −49.1% | +12.2% | 13.9% | 0.98% |
| 135 | $12.45 | −2.7% | $1.8B | +10.7% | +16.2% | 12 | 3.4× | +13.3% | – | – | 23.1% |
| 136 | $17.94 | +0.73% | $1.7B | +11.7% | +60.1% | 10 | 21.1× | – | +13.5% | 10.8% | 4.5% |
| 137 | $41.00 | −10.0% | $1.7B | +35.6% | +20.9% | 11 | 164× | −166% | +23.0% | 4.3% | – |
| 138 | $24.83 | −1.9% | $1.7B | +19.2% | +10.7% | 4 | – | −277% | +30.2% | −1351% | – |
| 139 | $2.61 | −8.7% | $1.7B | +39.8% | +120% | – | – | – | – | – | – |
| 140 | $27.71 | +0.29% | $1.7B | +11.2% | +5.6% | 8 | – | +35.8% | +9.6% | −1.4% | 2.0% |
| 141 | $17.61 | +1.3% | $1.7B | +10.6% | +17.7% | 1 | – | – | – | – | – |
| 142 | $149.03 | −1.1% | $1.7B | +13.3% | +8.5% | 13 | 19.4× | −38.5% | +31.6% | 37.2% | 1.4% |
| 143 | $26.43 | −4.9% | $1.6B | +12.5% | +25.7% | 2 | – | −302% | +10.6% | −78.6% | – |
| 144 | $70.05 | −3.3% | $1.6B | +11.9% | +12.2% | 5 | 50.0× | −65.1% | −4.7% | 0.95% | 1.4% |
| 145 | $47.34 | −10.9% | $1.5B | +55.5% | +28.3% | 7 | – | −64.9% | +15.1% | 1.0% | 0.00% |
| 146 | $7.27 | −9.8% | $1.5B | +10.2% | +10.2% | 9 | 66.1× | −45.0% | +35.9% | 0.59% | – |
| 147 | $43.81 | −5.1% | $1.5B | +23.3% | +21.4% | 17 | 33.2× | +27.4% | +39.0% | 14.7% | 0.00% |
| 148 | $52.18 | −2.8% | $1.5B | +42.2% | +18.9% | 10 | 134× | −418% | +81.5% | 12.0% | – |
| 149 | $6.45 | −0.46% | $1.5B | +10.6% | +8.0% | 2 | – | – | +10.0% | −9.3% | – |
| 150 | $84.90 | −1.2% | $1.4B | +87.4% | +6.5% | 5 | – | – | +0.32% | −3.9% | – |